4//SEC Filing
GenMark Diagnostics, Inc. 4
Accession 0001487371-15-000018
CIK 0001487371operating
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:31 PM ET
Size
10.2 KB
Accession
0001487371-15-000018
Insider Transaction Report
Form 4
Chakravarty Ingo
SVP, International
Transactions
- Award
Market Stock Units
2015-02-19+16,680→ 16,680 totalExercise: $0.00→ Common Stock (16,680 underlying) - Award
Common Stock
2015-02-19+19,182→ 65,025 total - Award
Stock Option (Right to Buy)
2015-02-19+60,600→ 60,600 totalExercise: $13.17Exp: 2025-02-19→ Common Stock (60,600 underlying)
Footnotes (4)
- [F1]The amount reported reflects restricted stock units granted to the reporting person pursuant to the Issuer's 2010 Equity Incentive Plan. Of the aggregate amount reported, (1) 16,680 represent restricted stock units which vest 25% on February 1, 2016 and the remaining shares subject to such award vest in 12 equal quarterly installments thereafter, and (2) 2,502 represent restricted stock units which vest 100% on February 1, 2016.
- [F2]25% of the shares subject to the award vest and become exercisable on February 1, 2016 and the remaining shares subject to the award vest and become exercisable in 36 equal monthly installments thereafter.
- [F3]Each market stock unit ("MSU") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index.
- [F4]The MSUs vest in three equal installments, on each of December 31, 2015, December 31, 2016, and December 31, 2017; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index.
Documents
Issuer
GenMark Diagnostics, Inc.
CIK 0001487371
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001487371
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 8:31 PM ET
- Size
- 10.2 KB